Figure 1

Trial profile. Legend: † 2 ETF in HIV-1 were serious adverse events. †† Patients facing an event (excluded, lost to follow up or new infection) were censored at the time of the last recorded visit and included in the survival analysis.
Trial profile. Legend: † 2 ETF in HIV-1 were serious adverse events. †† Patients facing an event (excluded, lost to follow up or new infection) were censored at the time of the last recorded visit and included in the survival analysis.